PGC-1α介导SNAIL2维持三阴乳腺癌干性表型的分子机制研究

基本信息
批准号:81872157
项目类别:面上项目
资助金额:55.00
负责人:李志高
学科分类:
依托单位:哈尔滨医科大学
批准年份:2018
结题年份:2022
起止时间:2019-01-01 - 2022-12-31
项目状态: 已结题
项目参与者:刘通,娄春,邹家威,张锐,何伟丹,李林
关键词:
肿瘤干细胞乳腺肿瘤三阴乳腺癌锌指转录因子2过氧化物酶体增殖物激活受体γ辅激活子1α
结项摘要

The maintenance of breast cancer cell stemness is the root cause of cancer progression. In our previous study, we found that PGC-1αis highly expressed in triple-negative breast cancer(TNBC), and it mediates the maintenance of cancer cell stemness. In addition, we also uncovered that the expression of PGC-1αis regulated by the transcriptional factor SNAIL2. However, the underlying mechanisms by which SNAIL2/PGC-1αaxis regulates TNBC stemness are still unclear. In Sum, in the current project we propose the hypothesis that: SNAIL2 promotes the expression of PGC-1α, and the upregulation further activates Hippo signaling pathway which maintains the cancer stem cell phenotypes. In this study, we will utilize ChIP、EMSA、DNaseI blotting and Luciferase reporter assay to explorethe molecular mechanisms of how SNAIL2 promotes PGC-1αexpression. Additionally, we will overexpress or knockdown/knockout SNAIL2 or PGC-1α to test the effects on Hippo pathway activation and stemness maintenance. We will also explore the correlation of SNAIL2 and PGC-1α expressions with patient survival and prognosis based on our clinical follow-up data. Our study aims at to demonstrate the mechanisms of TNBC malignancy based on the TNBC stem cell model and has the potential to identify new therapeutic targets.

乳腺癌细胞能够维持干性的能力是乳腺癌恶性生长的根本原因。通过研究我们发现PGC-1α在三阴乳腺癌细胞中高表达,PGC-1α参与维持三阴乳腺癌细胞的干性表型,且转录因子SNAIL2是影响PGC-1α表达的关键转录因子,但SNAIL2/PGC-1α发挥作用的具体分子机制不详。综上,本项目提出假设:SNAIL2可能通过转录激活PGC-1Α表达,影响Hippo通路进而参与维持三阴乳腺癌干细胞的干性表型。项目拟采用ChIP、EMSA、DNaseI足迹分析、萤光素酶报告基因实验,探讨SNAIL2调控PGC-1α表达的分子机制;并在三阴乳腺癌细胞模型中改变SNAIL2和PGC-1α表达,检测其对Hippo通路及三阴乳腺癌细胞干性表型的影响;统计分析临床随访资料,探讨SNAIL2和 PGC-1α的表达对三阴乳腺癌患者预后评估的价值,并且有望对三阴乳腺癌恶性生长的治疗提供潜在的干预靶点和实验依据。

项目摘要

乳腺癌细胞能够维持干性的能力是乳腺癌恶性生长的根本原因。通过前期研究我们发现PGC-1α在三阴乳腺癌细胞中高表达,PGC-1α参与维持三阴乳腺癌细胞的干性表型,且转录因子SNAIL2是影响PGC-1α表达的关键转录因子,但SNAIL2/PGC-1α发挥作用的具体分子机制不详。综上,本项目提出假设:SNAIL2可能通过转录激活PGC-1Α表达,影响Hippo通路进而参与维持三阴乳腺癌干细胞的干性表型。项目拟采用ChIP、EMSA、DNaseI足迹分析、萤光素酶报告基因实验,探讨SNAIL2调控PGC-1α表达的分子机制;并在三阴乳腺癌细胞模型中改变SNAIL2和PGC-1α表达,检测其对Hippo通路及三阴乳腺癌细胞干性表型的影响;统计分析临床随访资料,探讨SNAIL2和 PGC-1α的表达对三阴乳腺癌患者预后评估的价值,并且有望对三阴乳腺癌恶性生长的治疗提供潜在的干预靶点和实验依据。本项目通过一系列实验进一步发现,SNAIL2能够与PGC-1α启动子区域进行相互结合,激活PGC-1α表达。鉴定了PGC-1α与Hippo通路关键蛋白YAP1的结合位点。该位点的失活突变减少了PGC-1α与YAP1的结合,并降低YAP的磷酸化水平。YAP磷酸化水平的降低导致三阴乳腺癌肿瘤干细胞形成比例减少。对临床样本进行分析结果显示组织中高表达的SNAIL2及PGC-1α与三阴乳腺癌患者不良预后相关。上述研究结果证实SNAIL2/PGC-1α/Hippo通路是三阴乳腺癌干细胞形成的关键通路,具有临床转化潜力。本课题组同样完成多项横向课题,对乳腺癌侵袭、转移、耐药及化疗副反应等领域进行深入研究,为三阴乳腺癌的治疗提供新的见解。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

祁连山天涝池流域不同植被群落枯落物持水能力及时间动态变化

祁连山天涝池流域不同植被群落枯落物持水能力及时间动态变化

DOI:10.13885/j.issn.0455-2059.2020.06.004
发表时间:2020
3

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
4

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
5

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021

李志高的其他基金

相似国自然基金

1

蒲公英提取物通过CUEDC2影响三阴乳腺癌干细胞干性抑制其恶性表型的分子机制

批准号:81873054
批准年份:2018
负责人:韩淑燕
学科分类:H3210
资助金额:57.00
项目类别:面上项目
2

Caveolin-1介导乳腺癌干细胞化疗抵抗及干性维持的作用和分子机制研究

批准号:81402173
批准年份:2014
负责人:王志宇
学科分类:H1821
资助金额:23.00
项目类别:青年科学基金项目
3

调控三阴乳腺癌干细胞自我更新和干细胞特性维持的分子开关:miR-4319

批准号:81572603
批准年份:2015
负责人:贠红岩
学科分类:H1819
资助金额:50.00
项目类别:面上项目
4

低氧-HIF1α调控的LncRNA促三阴性乳腺癌干细胞干性维持与肿瘤转移的分子机制研究

批准号:81874199
批准年份:2018
负责人:柳满然
学科分类:H1810
资助金额:57.00
项目类别:面上项目